Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.
about
Chronic proton pump inihibitor therapy and calcium metabolismZinc and gastrointestinal diseaseZinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxideA Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.Optimizing bone health in older adults: the importance of dietary protein.Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesiumAdverse effects of long-term proton pump inhibitor therapy.Hip fracture risk in patients with a diagnosis of pernicious anemia.Proton pump inhibitors: Risks of long-term use.Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health InitiativeUse of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control studyDo proton pump inhibitors decrease calcium absorption?Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trialGastric juice: a barrier against infectious diseases.A Proton Pump Inhibitor's Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized StudyApical acidity decreases inhibitory effect of omeprazole on Mg(2+) absorption and claudin-7 and -12 expression in Caco-2 monolayers.Proton pump inhibitor associated hypomagnasaemia - a cause for concern?Omeprazole and refractory hypomagnesaemia.Proton pump-inhibiting drugs, calcium homeostasis, and bone health.Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm.The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study.The effect of proton pump-inhibiting drugs on mineral metabolism.Proton pump inhibitors and bone fractures?Influence of proton pump inhibitors and histamine H2 receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review.Safety of proton pump inhibitors: current evidence for osteoporosis and interaction with antiplatelet agents.Proton pump inhibitors and fracture risk: true effect or residual confounding?Fracture risk and bone mineral density reduction associated with proton pump inhibitors.Osteoporosis and polypharmacy.Gastric acid, calcium absorption, and their impact on bone health.A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate.The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.Indications and safety of proton pump inhibitor drug use in patients with cancer.Contemporary view of the clinical relevance of magnesium homeostasis.A benefit-risk assessment of the use of proton pump inhibitors in the elderly.Proton pump inhibitors use and change in bone mineral density.Omeprazole decreases magnesium transport across Caco-2 monolayers.Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates.
P2860
Q27016636-3FA3B30E-8F47-41A8-B507-097FC5E8BCF1Q28652224-3FAF5197-3075-42E6-A8A5-28E38C289495Q30568164-E9B04AC0-8935-482B-840A-C4218144C8A1Q33441225-471236DE-E20F-4D9B-BCA5-8F0EA2E04603Q33940198-F244EA6E-76A3-4D3B-81B7-87BAD12011ECQ33987564-6021EE08-F150-449A-B94E-87996BAFC900Q34009589-7851E22C-31FA-472F-B4EF-39E0BADAE264Q34140914-37966688-573D-40EA-8049-4A118B2DC884Q34167899-FCF190A6-F3FD-4B67-B8C2-6702D4253D2EQ34196326-D6550453-6EC5-434F-86FF-DD7EBFB7FD96Q34549406-011D97A2-7E72-44F7-8127-89C05F0BC402Q34554705-B251615F-1188-4FC1-B6D6-7A001AD1993AQ34557174-46B70A32-9523-4424-A84B-886FE0984B1BQ35229828-C4369B23-592B-4023-A29D-41BC526355E8Q35853968-EE7C22A4-A022-4BF5-8E57-D9479945B9C5Q36023592-08EC4A0A-4CBD-4D28-9E51-A5CE0CA854B8Q36037123-82B3D77A-1175-46ED-9ED9-4A8E5F611563Q36431083-4C201FA7-5E64-4745-9352-A31290A6AC7DQ36706785-1E95D376-CE49-42AE-B044-BCFB66C0BD9AQ36791405-0E7FAE4B-B6D6-49FD-AA5A-01BA53769781Q37078434-12CE8190-05E3-4160-80D8-76DC3F871C0AQ37294536-F0115D15-75AB-4E29-AE42-399B8C20A1ACQ37395858-FE5D73AB-9B7D-42F7-A023-711D57A9090AQ37406908-D7ADBDFA-ADBC-4A5D-8C41-679B8094A6D3Q37406912-967B8416-A724-4308-A0FA-2D0ABF93F92CQ37431931-5727FCB7-CA3F-48FC-A3A3-978D349568C2Q37738629-6DDF427D-FBDC-418E-98A3-660FDD2E4C88Q37784797-F0637B4D-19FA-42A5-8C58-136871C25A35Q37990890-5B9780F4-ED3B-4659-B84A-82C029608CB2Q38027084-89CB79A0-9A4A-450C-AE3F-3EF5E0DFB03FQ38072903-6343FD12-CF54-4A6C-8633-E766F9EFF10FQ38073139-36405194-CB87-42F6-97FE-3BA6ED3DA0EAQ38093799-2D9A993A-577A-43B1-B07F-B03A7BB4546EQ38104388-7692C967-B04A-4B45-BF50-B4AA2419F2EAQ38176746-038EEA51-7E32-4171-BD94-759DACDADF92Q38196383-997A66FE-CF47-4F2A-9CEA-BFA88AE54E60Q39724310-9DD393AA-0BBE-424F-B0DC-FF615616B20DQ41982621-5F9F58F9-6C1E-4E71-A759-AA341428ECC7Q43457054-7AC57183-D1E0-4989-8F9D-EBA4FB0D4E22Q46068063-4AA4D3BB-049A-4F0C-AF2F-F257BDFFC988
P2860
Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Hypochlorhydria from short-ter ...... m or zinc from food in humans.
@en
Hypochlorhydria from short-ter ...... m or zinc from food in humans.
@nl
type
label
Hypochlorhydria from short-ter ...... m or zinc from food in humans.
@en
Hypochlorhydria from short-ter ...... m or zinc from food in humans.
@nl
prefLabel
Hypochlorhydria from short-ter ...... m or zinc from food in humans.
@en
Hypochlorhydria from short-ter ...... m or zinc from food in humans.
@nl
P2093
P2860
P1476
Hypochlorhydria from short-ter ...... m or zinc from food in humans.
@en
P2093
Russell RR
Saltzman JR
Serfaty-Lacrosniere C
P2860
P304
P356
10.1080/07315724.1995.10718522
P577
1995-08-01T00:00:00Z